Molecular mechanisms of cisplatin resistance in ovarian cancer

Ovarian cancer is one of the most common malignant tumors of the female repro-ductive system.The majority of patients with advanced ovarian cancer are mainly treated with cisplatin-based chemotherapy.As the most widely used first-line anti-neoplastic drug,cisplatin produces therapeutic effects through multiple mechanisms.However,during clinical treat-ment,cisplatin resistance has gradually emerged,representing a challenge for patient outcome improvement.The mechanism of cisplatin resistance,while known to be complex and involve many processes,remains unclear.We hope to provide a new direction for pre-clin-ical and clinical studies through this review on the mechanism of ovarian cancer cisplatin resis-tance and methods to overcome drug resistance.